Skip to main content

Table 2 Overall survival for various characteristics based on Kaplan–Meier analysis

From: Negative impact of low body mass index on liver cirrhosis patients with hepatocellular carcinoma

Variables

Overall survival (d) mean (95 % CI)

p

BMI

 

3.6 × 10−13

 <23 kg/m2

353.9 (316.9–391.0)

 

 ≥23 kg/m2

571.8 (532.3–611.4)

 

Age

 

0.924

 <60 years

444.9 (397.6–492.1)

 

 ≥60 years

444.2 (406.8–481.5)

 

Gender

 

0.537

 Male

451.9 (413.7–490.2)

 

 Female

427.2 (382.8–471.6)

 

Diabetes

 

0.563

 Yes

440.6 (408.3–474.0)

 

 No

457.2 (388.0–526.5)

 

Alcohol

 

0.453

 Ever

425.8 (369.4–482.1)

 

 Never

451.4 (417.1–485.6)

 

Smoking

 

0.085

 Ever

411.6 (362.2–461.1)

 

 Never

462.1 (425.9–498.3)

 

AFP

 

0.651

 ≥400 μg/L

456.8 (405.2–508.4)

 

 <400 μg/L

433.7 (396.3–471.1)

 

Viral status

 

0.349

 HBV

432.8 (396.0–469.6)

 

 HCV

459.8 (408.3–511.3)

 

Previous treatment

 

0.502

 Yes

459.8 (405.3–514.3)

 

 No

432.7 (396.9–468.5)

 

Child–Pugh class

 

3.6 × 10−31

 A class

627.1 (592.0–662.2)

 

 B class

479.7 (435.0–524.5)

 

 C class

232.0 (198.9–265.2)

 

Extrahepatic metastasis

 

5.3 × 10−13

 Yes

202.4 (148.4–256.4)

 

 No

471.2 (440.7–501.7)

 

Infiltration of portal vein

 

1.4 × 10−13

 Yes

259.9 (228.0–290.8)

 

 No

513.2 (479.2–547.1)

 

Treatment after diagnosis

 

2.5 × 10–31

 Yes

617.2 (589.2–645.2)

 

 No

259.7 (232.5–286.9)

 

BCLC stage

 

1.4 × 10−36

 0 stage

696.3 (652.7–739.8)

 

 1 stage

678.8 (653.2–704.4)

 

 2 stage

544.8 (500.2–589.4)

 

 3 stage

299.6 (257.9–341.2)

 

 4 stage

232.0 (198.9–265.2)